< 0 1 0 1 O
18 1 3 1 3 B-upper_bound
years 4 9 4 9 I-upper_bound
of 10 12 10 12 O
age 13 16 13 16 B-age

Candidate 0 9 17 26 O
for 10 13 27 30 O
cytoreductive 14 27 31 44 B-treatment
surgery 28 35 45 52 I-treatment
with 36 40 53 57 O
hyperthermic 41 53 58 70 B-treatment
intraperitoneal 54 69 71 86 I-treatment
chemotherapy 70 82 87 99 I-treatment
( 83 84 100 101 I-treatment
CRS 84 87 101 104 I-treatment
/ 87 88 104 105 I-treatment
HIPEC 88 93 105 110 I-treatment
) 93 94 110 111 I-treatment

Concurrent 0 10 112 122 O
severe 11 17 123 129 O
medical 18 25 130 137 B-chronic_disease
problems 26 34 138 146 I-chronic_disease
unrelated 35 44 147 156 O
to 45 47 157 159 O
malignancy 48 58 160 170 B-cancer

Eastern 0 7 171 178 B-clinical_variable
Cooperative 8 19 179 190 I-clinical_variable
Oncology 20 28 191 199 I-clinical_variable
Group 29 34 200 205 I-clinical_variable
performance 35 46 206 217 I-clinical_variable
status 47 53 218 224 I-clinical_variable
score 54 59 225 230 I-clinical_variable
of 60 62 231 233 O
≤2 63 65 234 236 O
/ 65 66 236 237 O
Karnofsky 66 75 237 246 B-clinical_variable
performance 76 87 247 258 I-clinical_variable
status 88 94 259 265 I-clinical_variable
( 95 96 266 267 I-clinical_variable
KPS 96 99 267 270 I-clinical_variable
) 99 100 270 271 I-clinical_variable
≥70 101 104 272 275 O
% 104 105 275 276 I-lower_bound

Pregnant 0 8 277 285 B-pregnancy
women 9 14 286 291 B-gender

≥18 0 3 292 295 O
and 4 7 296 299 O
≤ 8 9 300 301 O
80 10 12 302 304 B-upper_bound
years 13 18 305 310 I-upper_bound
of 19 21 311 313 O
age 22 25 314 317 B-age

